Jeremy Blum, PhD

Jeremy received his BSE in Chemical Engineering from the University of Michigan and his PhD in Bioengineering from Rice University. Jeremy has over 15 years of experience advancing novel drug delivery and formulation technologies for vaccines and biologics.  Additionally, Jeremy worked 3 years in management consulting supporting early start-ups to large pharmaceuticals in program execution. Among Jeremy’s accomplishments are the following:

• Brought 4 novel platform research programs from early concept to clinical development.

• Developed the first adjuvanted formulation and associated analytical methods for trivalent non-replicating rotavirus vaccine.

• Led the cross-institutional adjuvanted inactivated poliovirus vaccine program at PATH which downselected novel IPV candidates.

• Established a network of university relationships in Iraq for advancing lab based scientific research.